Kyverna Therapeutics Ownership 2024 | Who Owns Kyverna Therapeutics Now?
Kyverna Therapeutics Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
PRUDENTIAL SECTOR FUNDS, INC. | 0.13% | 275,235 | 275,235 | - | Feb 29, 2024 |
PRUDENTIAL JENNISON SMALL CO FUND, INC. | 0.10% | 417,342 | 417,342 | - | Mar 28, 2024 |
PRUDENTIAL JENNISON BLEND FUND, INC. | 0.07% | 42,610 | 42,610 | - | Feb 29, 2024 |
BlackRock Advantage SMID Cap Fund, Inc. | 0.02% | 2,947 | 2,947 | - | Mar 28, 2024 |
Forethought Variable Insurance Trust | 0.00% | 2,466 | 2,466 | - | Mar 28, 2024 |
Voya INVESTORS TRUST | 0.00% | 18,219 | 18,219 | - | Mar 31, 2024 |
OHIO NATIONAL FUND INC | 0.00% | 6,160 | 6,160 | - | Mar 31, 2024 |
BLACKROCK LARGE CAP SERIES FUNDS, INC. | 0.00% | 3,139 | 3,139 | - | Feb 29, 2024 |
CARILLON SERIES TRUST | 0.00% | 1,089 | 1,089 | - | Mar 31, 2024 |
ADVANCED SERIES TRUST | 0.00% | 27,515 | 27,515 | - | Mar 28, 2024 |
COLUMBIA FUNDS SERIES TRUST I | 0.00% | 36,583 | 36,583 | - | Feb 29, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 7,329 | 7,329 | - | Mar 31, 2024 |
BLACKROCK FUNDS | 0.00% | 4,082 | 4,082 | - | Mar 28, 2024 |
FIRST TRUST EXCHANGE-TRADED FUND VIII | 0.00% | 65 | 65 | - | Feb 29, 2024 |
John Hancock Funds II | 0.00% | 6,888 | 6,888 | - | Feb 29, 2024 |
Kyverna Therapeutics's largest mutual fund holder by % of total assets is "PRUDENTIAL SECTOR FUNDS, INC.", owning 275.24K shares, compromising 0.13% of its total assets.
Kyverna Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Kyverna Therapeutics's stock was made by GILEAD SCIENCES, INC. on Feb 13 2024, selling 6,890,744 shares at - per share (valued at -). The last insider buy of KYTX was made by GILEAD SCIENCES, INC. on Feb 13 2024, buying 910,000 shares at $22.00 per share (worth $20.02M).
Kyverna Therapeutics Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | 2 | 11 | 18.18% |
Q3 2022 | - | 1 | - |
2 total buy trades, and 11 total sell trades (buy/sell ratio of 0.18%) were made by Kyverna Therapeutics's insiders, as of Q1 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | 1 | - | - |
Q3 2022 | - | - | - |
As of Q1 2024, Insider owners conducted 1 open market buy trades and 0 open market sell trades of Kyverna Therapeutics's stocks.